← Back to home

CKD Bio Corporation

Clinical trials sponsored by CKD Bio Corporation, explained in plain language.

CKD Bio Corporation 063160 KRX

A South Korean pharmaceutical and biotech company involved in drug development and manufacturing.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Browse trials soon ready across all sponsors →
Sort by